COMPARATIVE BIOSCIENCES A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH

Welcome to the Brand page for “COMPARATIVE BIOSCIENCES A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH”, which is offered here for In the statement, line 19, bioscience should be deleted, and biosciences should be inserted. the drawing is corrected to appear as follows: comparative biosciences, a translational approach to preclinical research;comparative biosciences;medical research; medical research services; medical and scientific research in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and t cell receptors; research and development in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and t cell receptors; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the field of toxicology, pharmacokinetics, pharmacology, dermatology, ocular studies, efficacy, good laboratory practices, histopathology, immunohistochemistry and t cell receptors;.

Its status is currently believed to be active. Its class is unavailable. “COMPARATIVE BIOSCIENCES A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH” is believed to be currently owned by “ELIM Holdings, LLC”.